Mirae Asset Global Etfs Holdings Ltd. Rezolute, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rezolute, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 36,645 shares of RZLT stock, worth $336,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,645Holding current value
$336,401% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RZLT
# of Institutions
95Shares Held
59.4MCall Options Held
713KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$129 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$36.9 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$32.7 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$27.9 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$27.8 Million11.22% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $356M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...